Production (Stage)
Amphastar Pharmaceuticals, Inc.
AMPH
$24.47
$0.271.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 236.88M | 221.65M | 250.49M | 217.78M | 289.56M |
| Total Receivables | 145.39M | 144.04M | 144.98M | 132.08M | 138.90M |
| Inventory | 185.48M | 153.74M | 130.32M | 122.41M | 115.49M |
| Prepaid Expenses | 11.77M | 12.21M | 17.72M | 7.95M | 8.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.44M | 2.44M | 2.44M | 2.44M | 2.44M |
| Total Current Assets | 587.96M | 534.07M | 545.95M | 482.65M | 555.08M |
|
|
|||||
| Total Current Assets | 587.96M | 534.07M | 545.95M | 482.65M | 555.08M |
| Net Property, Plant & Equipment | 353.76M | 344.63M | 327.52M | 320.57M | 320.39M |
| Long-term Investments | 3.16M | 3.05M | 3.26M | 3.13M | 3.15M |
| Goodwill | 3.16M | 3.05M | 3.26M | 3.13M | 3.15M |
| Total Other Intangibles | 581.37M | 587.61M | 591.54M | 597.72M | 603.91M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 94.12M | 97.12M | 76.92M | 77.51M | 76.62M |
| Total Assets | 1.63B | 1.58B | 1.55B | 1.49B | 1.57B |
|
|
|||||
| Total Accounts Payable | 52.81M | 30.51M | 34.09M | 31.78M | 36.53M |
| Total Accrued Expenses | 105.94M | 111.57M | 104.89M | 82.20M | 192.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.97M | 7.04M | 4.46M | 4.25M | 4.37M |
| Total Finance Division Other Current Liabilities | 32.33M | 24.64M | 15.57M | 18.75M | 22.19M |
| Total Other Current Liabilities | 32.33M | 24.64M | 15.57M | 18.75M | 22.19M |
| Total Current Liabilities | 199.05M | 173.76M | 159.01M | 136.97M | 255.17M |
|
|
|||||
| Total Current Liabilities | 199.05M | 173.76M | 159.01M | 136.97M | 255.17M |
| Long-Term Debt | 603.48M | 601.41M | 595.96M | 586.33M | 593.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 41.09M | 42.11M | 29.43M | 30.01M | 29.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.38M | 27.90M | 33.10M | 24.87M | 24.05M |
| Total Liabilities | 874.99M | 845.17M | 817.50M | 778.18M | 901.96M |
|
|
|||||
| Common Stock & APIC | 509.11M | 505.41M | 496.43M | 487.58M | 476.08M |
| Retained Earnings | 594.07M | 568.79M | 530.82M | 490.39M | 452.45M |
| Treasury Stock & Other | -351.90M | -341.90M | -299.58M | -264.63M | -256.17M |
| Total Common Equity | 751.28M | 732.30M | 727.68M | 713.35M | 672.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 751.28M | 732.30M | 727.68M | 713.35M | 672.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 751.28M | 732.30M | 727.68M | 713.35M | 672.36M |
|
|
|||||